Ivaska Kaisa K, Gerdhem Paul, Akesson Kristina, Garnero Patrick, Obrant Karl J
Clinical and Molecular Osteoporosis Research Unit, Department of Orthopaedics, Lund University, Malmö University Hospital, Malmö, Sweden.
J Bone Miner Res. 2007 Aug;22(8):1155-64. doi: 10.1359/jbmr.070505.
In this longitudinal, prospective, and population-based study (n = 1044), seven BTMs were assessed before and after trauma in 113 elderly women (85 with fractures). Markers were not altered in the immediate postfracture period but were clearly elevated during fracture repair. Recent fracture should thus be taken into account when markers are used in clinical practice.
Fracture may influence the levels of bone turnover markers (BTM) and have implications for their use in clinical practice. In this longitudinal, prospective, and population-based study, we assessed prefracture levels of BTMs and compared them with postfracture levels of the same individuals immediately after fracture and during fracture repair. This is the first study in which the effect of fracture on bone markers has been evaluated with prefracture samples available.
Serum and urine were collected at the emergency unit from 85 women (77.9 +/- 1.8 yr) who sustained a fracture after low-energy trauma and 28 controls (77.8 +/- 2.0 yr) with similar trauma but no fracture. All were participants of the Malmö OPRA study (n = 1044), and pretrauma samples were collected 1.05 +/- 0.85 yr before. Bone turnover was assessed by seven different BTMs reflecting different stages of bone metabolism {C-terminal cross-linked telopeptides of type I collagen [S-CTX], S-TRACP5b, N-terminal propeptides of type I collagen [S-PINP], serum osteocalcin (S-OC[1-49] and S-TotalOC), urinary deoxypyridinoline [U-DPD], and urinary osteocalcin [U-OC]}.
BTMs sampled within a few hours after fracture were not altered from preinjury levels. Both bone formation and bone resorption markers were, however, significantly increased 4 mo after fracture. The elevation was most pronounced after hip fracture. Bone turnover remained elevated up to 12 mo after fracture.
We believe this study extends our knowledge on the skeletal postfracture metabolic processes. In addition, it may provide a basis for future means to monitor pharmacological intervention promoting fracture healing.
在这项纵向、前瞻性、基于人群的研究(n = 1044)中,对113名老年女性(85名骨折患者)创伤前后的七种骨转换标志物(BTM)进行了评估。骨折后即刻这些标志物未发生改变,但在骨折修复期间明显升高。因此,在临床实践中使用标志物时应考虑近期骨折情况。
骨折可能影响骨转换标志物(BTM)水平,并对其在临床实践中的应用产生影响。在这项纵向、前瞻性、基于人群的研究中,我们评估了BTM的骨折前水平,并将其与同一患者骨折后即刻及骨折修复期间的骨折后水平进行比较。这是第一项利用可用的骨折前样本评估骨折对骨标志物影响的研究。
在急诊室收集了85名女性(77.9±1.8岁)的血清和尿液,这些女性在低能量创伤后发生骨折,以及28名有类似创伤但未骨折的对照者(77.8±2.0岁)。所有患者均为马尔默OPRA研究(n = 1044)的参与者,创伤前样本于1.05±0.85年前采集。通过七种不同的BTM评估骨转换,这些标志物反映骨代谢的不同阶段{Ⅰ型胶原C末端交联端肽[S-CTX]、S-TRACP5b、Ⅰ型胶原N末端前肽[S-PINP]、血清骨钙素(S-OC[1-49]和S-总OC)、尿脱氧吡啶啉[U-DPD]和尿骨钙素[U-OC]}。
骨折后数小时内采集的BTM与受伤前水平无变化。然而,骨折后4个月时骨形成和骨吸收标志物均显著增加。髋部骨折后升高最为明显。骨折后骨转换一直升高至12个月。
我们认为这项研究扩展了我们对骨折后骨骼代谢过程的认识。此外,它可能为未来监测促进骨折愈合的药物干预手段提供基础。